Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dubinsky

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurology|August 1, 1988
Patterns of cerebral glucose metabolism in patients with partial seizuresW H Theodore, D Fishbein, R Dubinsky
Clinical Neuropharmacology|August 1, 1990
Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollisW Koller, B Vetere-Overfield, C Gray, et al.
Clinical Neuropharmacology|April 1, 1992
Classification of essential tremorW C Koller, K Busenbark, C Gray, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Neurology|April 1, 1996
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopaR Pahwa, K Lyons, D McGuire, et al.
Cancer Genetics and Cytogenetics|May 23, 2001
Modified order of allelic replication in lymphoma patients at different disease stagesA Amiel, A Elis, D Blumenthal, et al.
Archives of Neurology|February 1, 1991
Posttraumatic torticollisD D Truong, R Dubinsky, N Hermanowicz, et al.
Psychopharmacology|March 24, 2021
Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant miceKristyn N Borrelli, Carly R Langan, Kyra R Dubinsky, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD M Simpson, A Blitzer, A Brashear, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurology|August 1, 1988
Patterns of cerebral glucose metabolism in patients with partial seizuresW H Theodore, D Fishbein, R Dubinsky
Clinical Neuropharmacology|August 1, 1990
Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollisW Koller, B Vetere-Overfield, C Gray, et al.
Clinical Neuropharmacology|April 1, 1992
Classification of essential tremorW C Koller, K Busenbark, C Gray, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Neurology|April 1, 1996
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopaR Pahwa, K Lyons, D McGuire, et al.
Cancer Genetics and Cytogenetics|May 23, 2001
Modified order of allelic replication in lymphoma patients at different disease stagesA Amiel, A Elis, D Blumenthal, et al.
Archives of Neurology|February 1, 1991
Posttraumatic torticollisD D Truong, R Dubinsky, N Hermanowicz, et al.
Psychopharmacology|March 24, 2021
Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant miceKristyn N Borrelli, Carly R Langan, Kyra R Dubinsky, et al.
Lancet (London, England)|January 16, 1988
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)R Yarchoan, C F Perno, R V Thomas, et al.
Neurology|May 7, 2008
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD M Simpson, A Blitzer, A Brashear, et al.
Pageof 1